Study of Arimoclomol in Inclusion Body Myositis (IBM)

NCT02753530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

Inclusion Body Myositis

Interventions

DRUG: Arimoclomol
OTHER: Placebo

Sponsor

ZevraDenmark

Collaborators

[object Object]
[object Object]